Search details
1.
Identifying Optimal Methods for Addressing Confounding Bias When Estimating the Effects of State-level Policies.
Epidemiology
; 34(6): 856-864, 2023 11 01.
Article
in English
| MEDLINE | ID: mdl-37732843
2.
Discontinuation of Buprenorphine Treatment for Opioid Use Disorder During the Coronavirus Disease-2019 Pandemic: A Multilevel Framework.
Med Care
; 61(2): 95-101, 2023 02 01.
Article
in English
| MEDLINE | ID: mdl-36630560
3.
Prevalence of Buprenorphine Providers Requiring Cash Payment From Insured Women Seeking Opioid Use Disorder Treatment.
Med Care
; 61(6): 377-383, 2023 06 01.
Article
in English
| MEDLINE | ID: mdl-37083603
4.
County-level Factors and Treatment Access Among Insured Women With Opioid Use Disorder.
Med Care
; 61(12): 816-821, 2023 12 01.
Article
in English
| MEDLINE | ID: mdl-37199507
5.
An Exploratory Analysis of Differential Prescribing of High-Risk Opioids by Insurance Type Among Patients Seen by the Same Clinician.
J Gen Intern Med
; 38(7): 1681-1688, 2023 05.
Article
in English
| MEDLINE | ID: mdl-36745303
6.
Buprenorphine Treatment Episodes During the First Year of COVID: a Retrospective Examination of Treatment Initiation and Retention.
J Gen Intern Med
; 38(3): 733-737, 2023 02.
Article
in English
| MEDLINE | ID: mdl-36474004
7.
US state laws relevant to incentives for health behavior: A qualitative analysis.
Prev Med
; 176: 107645, 2023 Nov.
Article
in English
| MEDLINE | ID: mdl-37494973
8.
Systematic Identification and Categorization of Opioid Prescribing and Dispensing Policies in 16 States and Washington, DC.
Pain Med
; 24(2): 130-138, 2023 02 01.
Article
in English
| MEDLINE | ID: mdl-35984301
9.
Urine drug testing in the context of opioid analgesic prescribing for chronic pain: a content analysis of U.S. state laws in 2022.
Pain Med
; 24(12): 1306-1317, 2023 Dec 01.
Article
in English
| MEDLINE | ID: mdl-37551941
10.
Medical marijuana access and prolonged opioid use among adolescents and young adults.
Am J Addict
; 32(5): 479-487, 2023 09.
Article
in English
| MEDLINE | ID: mdl-37291067
11.
Will the End of the X-Waiver Expand Access to Buprenorphine Treatment? Achieving the Full Potential of the 2023 Consolidated Appropriations Act.
Subst Abus
; 44(3): 108-111, 2023 07.
Article
in English
| MEDLINE | ID: mdl-37675897
12.
National Trends in Buprenorphine Treatment for Opioid Use Disorder From 2007 to 2018.
Subst Abus
; 44(3): 154-163, 2023 07.
Article
in English
| MEDLINE | ID: mdl-37278310
13.
Exploring the Association of State Policies and the Trajectories of Buprenorphine Prescriber Patient Caseloads.
Subst Abus
; 44(3): 136-145, 2023 07.
Article
in English
| MEDLINE | ID: mdl-37401501
14.
"The Problem's Bigger than We Are": Understanding How Local Factors Influence Child Welfare Responses to Substance Use in Pregnancy, A Qualitative Study.
Child Welfare
; 101(2): 193-224, 2023.
Article
in English
| MEDLINE | ID: mdl-38784918
15.
Rapid Discontinuation of Chronic, High-Dose Opioid Treatment for Pain: Prevalence and Associated Factors.
J Gen Intern Med
; 37(7): 1603-1609, 2022 05.
Article
in English
| MEDLINE | ID: mdl-34608565
16.
Spatial and temporal trends in the diagnosis of opioid-related problems in commercially-insured adolescents and young adults.
Prev Med
; 163: 107194, 2022 10.
Article
in English
| MEDLINE | ID: mdl-35970406
17.
Subsequent Buprenorphine Treatment Following Emergency Physician Buprenorphine Prescription Fills: A National Assessment 2019 to 2020.
Ann Emerg Med
; 79(5): 441-450, 2022 05.
Article
in English
| MEDLINE | ID: mdl-35305851
18.
Laws for expanding access to medications for opioid use disorder: a legal analysis of 16 states & Washington D.C.
Am J Drug Alcohol Abuse
; 48(4): 492-503, 2022 07 04.
Article
in English
| MEDLINE | ID: mdl-35772010
19.
A bridge too far? Distance to waivered physicians and utilization of buprenorphine treatment for opioid use disorder in West Virginia Medicaid.
Subst Abus
; 43(1): 682-690, 2022.
Article
in English
| MEDLINE | ID: mdl-35099362
20.
Sociodemographic differences in quality of treatment to Medicaid enrollees receiving buprenorphine.
Subst Abus
; 43(1): 1057-1071, 2022 12.
Article
in English
| MEDLINE | ID: mdl-35442178